MEUD.L vs. NOVN.SW

Last updated Jun 9, 2026

MEUD.L (Lyxor Core STOXX Europe 600 (DR) - UCITS ETF Acc) is Europe Equities fund tracking the MSCI Europe NR EUR, while NOVN.SW (Novartis AG) is a stock. Over the past 10 years, MEUD.L returned 10.52%/yr vs 13.11%/yr for NOVN.SW. At a 0.48 correlation, their price movements are largely independent.

Performance

MEUD.L vs. NOVN.SW - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in Lyxor Core STOXX Europe 600 (DR) - UCITS ETF Acc (MEUD.L) and Novartis AG (NOVN.SW). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

MEUD.L is traded in GBp, while NOVN.SW is traded in CHF. To make them comparable, the NOVN.SW values have been converted to GBp using the latest available exchange rates.

Returns By Period

In the year-to-date period, MEUD.L achieves a 6.17% return, which is significantly lower than NOVN.SW's 9.64% return. Over the past 10 years, MEUD.L has underperformed NOVN.SW with an annualized return of 10.52%, while NOVN.SW has yielded a comparatively higher 13.11% annualized return.

MEUD.L

• 1D: 0.06%
• 1M: 2.27%
• YTD: 6.17%
• 6M: 8.63%
• 1Y: 18.55%
• 3Y*: 14.23%
• 5Y*: 9.58%
• 10Y*: 10.52%

NOVN.SW

• 1D: 2.38%
• 1M: 2.09%
• YTD: 9.64%
• 6M: 13.56%
• 1Y: 29.09%
• 3Y*: 16.78%
• 5Y*: 16.98%
• 10Y*: 13.11%

*Multi-year figures are annualized to reflect compound growth (CAGR)

MEUD.L vs. NOVN.SW - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
MEUD.L Lyxor Core STOXX Europe 600 (DR) - UCITS ETF Acc	6.17%	26.51%	3.65%	13.48%	-5.04%	17.06%	3.85%	20.40%	-9.59%	15.43%
NOVN.SW Novartis AG	9.64%	36.16%	2.41%	16.79%	19.98%	-2.76%	0.15%	26.43%	12.15%	10.83%

Correlation

The correlation between MEUD.L and NOVN.SW is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.34
Correlation (3Y) Calculated over the trailing 3-year period	0.32
Correlation (5Y) Calculated over the trailing 5-year period	0.34
Correlation (10Y) Calculated over the trailing 10-year period	0.44
Correlation (All Time) Calculated using the full available price history since Apr 4, 2013	0.48

The correlation between MEUD.L and NOVN.SW shifts across timeframes, from 0.32 (3 years) to 0.48 (all time), reflecting how their relationship changes across market environments.

Return for Risk

MEUD.L vs. NOVN.SW — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MEUD.L

MEUD.L Risk / Return Rank: 46
MEUD.L Sharpe Ratio Rank: 49
MEUD.L Sortino Ratio Rank: 48
MEUD.L Omega Ratio Rank: 51
MEUD.L Calmar Ratio Rank: 39
MEUD.L Martin Ratio Rank: 43

NOVN.SW

NOVN.SW Risk / Return Rank: 75
NOVN.SW Sharpe Ratio Rank: 79
NOVN.SW Sortino Ratio Rank: 72
NOVN.SW Omega Ratio Rank: 72
NOVN.SW Calmar Ratio Rank: 77
NOVN.SW Martin Ratio Rank: 77

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MEUD.L vs. NOVN.SW - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lyxor Core STOXX Europe 600 (DR) - UCITS ETF Acc (MEUD.L) and Novartis AG (NOVN.SW). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MEUD.L	NOVN.SW	Difference
Sharpe ratio: Return per unit of total volatility	1.52	1.60	-0.08
Sortino ratio: Return per unit of downside risk	2.15	2.09	+0.06
Omega ratio: Gain probability vs. loss probability	1.29	1.28	+0.01
Calmar ratio: Return relative to maximum drawdown	1.75	2.38	-0.62
Martin ratio: Return relative to average drawdown	6.35	6.14	+0.21
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MEUD.L vs. NOVN.SW - Sharpe Ratio Comparison

The current MEUD.L Sharpe Ratio is 1.52, which is comparable to the NOVN.SW Sharpe Ratio of 1.60. The chart below compares the historical Sharpe Ratios of MEUD.L and NOVN.SW, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	MEUD.L	NOVN.SW	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.52	1.60	-0.08
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.60	0.92	-0.32
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.62	0.69	-0.07
Sharpe Ratio (All Time) Calculated using the full available price history	0.45	0.68	-0.23

Drawdowns

MEUD.L vs. NOVN.SW - Drawdown Comparison

The maximum MEUD.L drawdown since its inception was -28.57%, smaller than the maximum NOVN.SW drawdown of -30.23%. Use the drawdown chart below to compare losses from any high point for MEUD.L and NOVN.SW.

Drawdown Indicators

	MEUD.L	NOVN.SW	Difference
Max Drawdown Largest peak-to-trough decline	-28.57%	-30.23%	+1.66%
Max Drawdown (1Y) Largest decline over 1 year	-10.53%	-12.98%	+2.45%
Max Drawdown (3Y) Largest decline over 3 years	-12.61%	-15.76%	+3.15%
Max Drawdown (5Y) Largest decline over 5 years	-17.09%	-15.76%	-1.33%
Max Drawdown (10Y) Largest decline over 10 years	-28.57%	-19.62%	-8.95%
Current Drawdown Current decline from peak	-1.71%	-10.49%	+8.78%
Average Drawdown Average peak-to-trough decline	-6.90%	-6.94%	+0.04%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.91%	4.99%	-2.08%

Volatility

MEUD.L vs. NOVN.SW - Volatility Comparison

The current volatility for Lyxor Core STOXX Europe 600 (DR) - UCITS ETF Acc (MEUD.L) is 3.16%, while Novartis AG (NOVN.SW) has a volatility of 6.62%. This indicates that MEUD.L experiences smaller price fluctuations and is considered to be less risky than NOVN.SW based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MEUD.L	NOVN.SW	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.16%	6.62%	-3.46%
Volatility (6M) Calculated over the trailing 6-month period	10.20%	14.09%	-3.89%
Volatility (1Y) Calculated over the trailing 1-year period	12.17%	19.33%	-7.16%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.00%	18.49%	-2.49%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.94%	18.96%	-2.02%

Dividends

MEUD.L vs. NOVN.SW - Dividend Comparison

MEUD.L has not paid dividends to shareholders, while NOVN.SW's dividend yield for the trailing twelve months is around 3.19%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
MEUD.L Lyxor Core STOXX Europe 600 (DR) - UCITS ETF Acc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOVN.SW Novartis AG	3.19%	3.19%	3.72%	3.77%	3.91%	3.94%	3.72%	3.27%	3.98%	3.98%	4.35%	3.58%

Frequently Asked Questions

Can I hold both MEUD.L and NOVN.SW in my portfolio?

MEUD.L and NOVN.SW have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.